Found: 7
Select item for more details and to access through your institution.
Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study).
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 10, p. 3541, doi. 10.3390/jcm12103541
- By:
- Publication type:
- Article
Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study).
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 1052, doi. 10.3390/cancers16051052
- By:
- Publication type:
- Article
Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1713, doi. 10.3390/cancers14071713
- By:
- Publication type:
- Article
Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 3, p. 488, doi. 10.1002/ijc.34733
- By:
- Publication type:
- Article
Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Endothelium-specific overexpression of human vascular endothelial growth factor-D in mice leads to increased tumor frequency and a reduced lifespan.
- Published in:
- Journal of Gene Medicine, 2012, v. 14, n. 3, p. 182, doi. 10.1002/jgm.2608
- By:
- Publication type:
- Article
Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study.
- Published in:
- British Journal of Surgery, 2023, v. 110, n. 8, p. 931, doi. 10.1093/bjs/znac424
- By:
- Publication type:
- Article